Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 250
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Community-based interventions to control urogenital schistosomiasis in dam communities

    Urogenital schistosomiasis is a snail-borne infection having a huge socioeconomic impact on underserved...

    Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Backer Badge Funded